Coenzyme Q10 for heart failure (Cochrane) — Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
Ho MJ, Li ECK, Wright JM
Published in Cochrane Database of Systematic Reviews
Methodology
Cochrane systematic review and meta-analysis of randomized, placebo-controlled trials of coenzyme Q10 for primary hypertension.
Key Findings
Pooled analysis of the higher-quality trials found no statistically significant effect of CoQ10 on systolic or diastolic blood pressure.
Conclusions
There is currently no reliable evidence that coenzyme Q10 lowers blood pressure in primary hypertension.
Limitations
Few eligible trials and small total sample; earlier positive findings were driven by lower-quality studies.
Supplements Studied
Pooled analysis found no statistically significant effect of CoQ10 on systolic or diastolic blood pressure.
Outcomes Measured
Pooled analysis found no statistically significant effect of CoQ10 on blood pressure.
Pooled analysis of the higher-quality trials found no statistically significant effect of CoQ10 on systolic or diastolic blood pressure.
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
Cochrane (no commercial funding)
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.